Litcius/Paper detail

The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans

Jonathan Bauman, Angela C. Doran, Gabrielle M. Gualtieri, Brian Hee, Timothy J. Strelevitz, Matthew A. Cerny, Christopher Banfield, Anna Plotka, Xiaoxing Wang, Vivek S. Purohit, Martin E. Dowty

2024Drug Metabolism and Disposition12 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryPharmacologyPharmacokineticsCYP2C8MetaboliteVolume of distributionTyrosine-kinase inhibitorMetabolismBioavailabilityGlutathioneCYP1A2CYP3ACytochrome P450BiochemistryCYP3A4Internal medicineEnzymeBiologyMedicineCancerColorectal Cancer Treatments and StudiesHair Growth and DisordersAutoimmune Bullous Skin Diseases
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans | Litcius